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A B S T R A C T   
Background: It remains unclear whether a specific chest CT characteristic is associated with the clinical severity of 
COVID-19. This meta-analysis was performed to assess the relationship between different chest CT features and 
severity of clinical presentation in COVID-19. 
Methods: PubMed, Embase, Scopus, web of science databases (WOS), Cochrane library, and Google scholar were 
searched up to May 19, 2020 for observational studies that assessed the relationship of different chest CT 
manifestations and the severity of clinical presentation in COVID-19 infection. Risk of bias assessment was 
evaluated applying the Newcastle-Ottawa Scale. A random-effects model or fixed-effects model, as appropriately, 
were used to pool results. Heterogeneity was assessed using Forest plot, Cochran’s Q test, and I2. Publication bias 
was assessed applying Egger’s test. 
Results: A total of 18 studies involving 3323 patients were included. Bronchial wall thickening (OR 11.64, 95% CI 
1.81–74.66) was more likely to be associated with severe cases of COVID-19 infection, followed by crazy paving 
(OR 7.60, 95% CI 3.82–15.14), linear opacity (OR 3.27, 95% CI 1.10–9.70), and GGO (OR 1.37, 95% CI 
1.08–1.73). However, there was no significant association between the presence of consolidation and severity of 
clinical presentation (OR 2.33, 95% CI 0.85–6.36). Considering the lesion distribution bilateral lung involvement 
was more frequently associated with severe clinical presentation (OR 3.44, 95% CI 1.74–6.79). 
Conclusions: Our meta-analysis of observational studies indicates some specific chest CT features are associated 
with clinical severity of COVID-19.   
1. Introduction 
Corona Virus Disease 2019 (COVID-19), caused by severe acute 
respiratory syndrome coronavirus-2 (SARS-CoV-2), has been spreading 
throughout the world threatening the global health condition. COVID- 
19 infection causes a spectrum of respiratory illness ranges from a 
mild pneumonia to the critically ill and fatal cases of Acute Respiratory 
Distress Syndrome (ARDS).1–3 The timely identification and successful 
treatment of severe and critical cases of COVID-19 are essential to 
reduce the complications and mortality of the disease. Many studies 
aimed to find the disease severity-related factors in the clinical practice 
resulting in identification of some clinical, laboratory, and imaging 
factors as the predictors of disease severity.3,4 
Chest CT scan is a frequently used imaging tool for the early detec-
tion and monitoring of patients affected by COVID-19 due to the facts 
that it is relatively easy to perform and can produce fast diagnosis. 
Typical CT features of confirmed COVID-19 pneumonia have been 
shown to be helpful in evaluation of the severity and extent of dis-
ease.5,6 Multilobular infiltration, accounted for the highest score in 
MuLBSTA system (multilobular infiltration, hypo-lymphocytosis, bac-
terial co-infection, smoking history, hypertension, and age) for pre-
dicting the mortality in patients with viral pneumonia,7 has been more 
frequently reported in patients with severe and critical types of COVID- 
19 infection compared to the common types.3,5,6 The detailed imaging 
features in various clinical types of COVID-19 infection have been 
investigated in several studies indicating significant differences between 
common and severe cases.3,6,8 
Exploring the chest CT features in the spectrum of clinical presen-
tation of the COVID-19 infection can help us to predict outcome and 
support clinical decision making. Although several studies indicated 
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some CT features are associated with severe types of COVID-19 infec-
tion, as far as we know, there is no meta-analysis of these findings. Thus, 
we aimed to quantitatively summarize results from published studies to 
date to identify the CT features which determine the severity of COVID- 
19 infection. 
2. Methods 
2.1. Search strategy and selection criteria 
We searched for studies of any design and in any setting that 
included patients with COVID-19 infection and reported disease severity 
as well as chest CT characteristics of the patients. We initially did not 
limit our study by language. 
The aim of this systematic review was to quantitatively assess the 
association of clinical severity of COVID-19 infection with the chest CT 
characteristics. The clinical severity of the disease defined as common 
type, which included all patients with fever, cough, or other respiratory 
symptoms with or without CT manifestation of pneumonia, and severe 
type, which included the patients with any of the following condition:1) 
respiratory rate ≥30 breaths per minute; 2) finger of oxygen saturation 
≤93% in a resting state; 3) arterial oxygen tension (PaO2)/inspiratory 
oxygen fraction (FiO2) ≤300 mmHg (1 mmHg=0.133 kPa); 4) respira-
tory failure and mechanical ventilation requirement; 5) shock; 6) pa-
tients with other organ failure needed intensive care unit (ICU) 
monitoring treatment.9 
We searched PubMed, Embase, Scopus, web of science databases 
(WOS), Cochrane library, and Google scholar from January 1, 2020 up 
to May 19, 2020 applying the following search terms: Coronavirus OR 
covid-19 OR 2019-CoV OR CoV OR severe acute respiratory syndrome 
coronavirus 2 OR SARS-CoV-2 AND CT scan OR Computed tomography 
OR CT image* OR CT find* OR CT manifestation* OR CT Feature* OR 
Chest CT AND Severity OR Refractory OR Critical OR Emergency OR ICU 
admission. 
2.2. Data extraction 
We screened titles and abstracts, reviewed full texts, extracted data, 
and assessed risk of bias by two authors independently. We resolved 
disagreements by consensus. We included the studies met the following 
eligibility criteria: 1) the publications were original articles with full 
text; 2) the studies included patients with laboratory- confirmed COVID- 
Fig. 1. Flow diagram of literature search and study selection.  
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19 infection; 3) the studies reported information on clinical severity of 
the disease; 4) at least one of the chest CT features of COVID-19 has been 
reported. Studies were excluded if 1) the full text was not in English; 2) 
the studied populations were children or pregnant women; 3) the study 
was case report or clinical trial. 
We extracted data for study identifier, study sample size, mean or 
median age of the participants, gender distribution, disease severity 
classification, results of chest CT imaging features, the number of pa-
tients with each corresponding imaging features considering disease 
severity classification. 
2.3. Data analysis 
All Statistical analyses were performed using Stata version 14 (Sta-
taCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: 
StataCorp LP.). We employed “metaprop” command to calculate the 
pooled prevalence estimates of chest CT features with 95% confidence. 
The associations between chest CT features and severity of disease, were 
expressed as odds ratios (ORs) and 95% confidence intervals (CIs). 
Heterogeneity among the primary studies was evaluated by the forest 
plots, Cochran’s Q statistic, and I2 statistic. A random-effects model was 
used if heterogeneity was high (I2 > 50%); otherwise, a fixed-effects 
model was applied. Also, the publication bias was formally tested with 
Egger’s regression asymmetry tests to determine the asymmetry of the 
funnel plots, where p <0.10 was considered as evidence of bias. 
3. Results 
3.1. Literature retrieval 
A total of 1587 related records have been identified in the initial 
retrieval. Upon removal of duplication, 1158 records have been 
screened against the title and abstract. Full text of 60 studies has been 
assessed for eligibility. We identified 18 studies for our systematic re-
view. Studies were all observational in nature. All included studies were 
retrospective but for one that was prospective.10 These 18 studies ful-
filled criteria for including in the meta-analysis (Fig. 1, Table 1). 
3.2. Characteristics of the included studies and risk of bias quality 
assessment 
The total of 18 articles included 3323 patients with laboratory- 
confirmed COVID-19 infection. All included articles reported data on 
comparison of chest CT features of the COVID-19 infection in patients 
with various disease severities, but for two studies1,11 that included 
only common type of COVID-19 infection. Different features of CT im-
aging had been reported in the included studies. However, the 
frequently reported features were ground glass opacity (GGO), reported 
in 15 studies,1–6,8,11–19 consolidation, reported in 10 stud-
ies,1,3,5,6,11,12,15–18 linear opacity, reported in 4 studies,1,3,6,17 
bronchial wall thickening, reported in 3 studies,5,6,15 crazy paving, 
reported in 2 studies,6,17 and bilateral lung involvement, reported in 15 
studies2–6,8,10,12–15,17–20 (Table 1). Risk of bias was generally low 
after considering the observational designs (Supplementary Table 1). 
Fig. 2. Forest plot showing the association between ground glass opacity in chest CT images and severity of clinical presentation.  
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3.3. Pattern of lesions 
Twelve studies were included to explore the association between the 
presence of GGO in CT images and clinical severity of the disease. 
Compared with the common type, the pooled OR for the presence of 
GGO in CT images of patients with severe disease was 1.37 (95% CI 
1.08–1.73, I2= 0.0%, P for heterogeneity= 0.486) (Fig. 2). Eight studies 
were included to explore the association between the presence of 
consolidation in CT images and clinical severity of the disease. The 
pooled OR for the presence of consolidation in CT images of patients 
with severe disease, compared to the common type, was 2.33 (95% CI 
0.85–6.36, I2= 74.5%, P for heterogeneity= 0.000) (Fig. 3). Three 
studies were included to explore the association between the presence of 
linear opacity in CT images and clinical severity of the disease. 
Compared with the common type, the pooled OR for the presence of 
linear opacity in CT images of patients with severe disease was 3.27 
(95% CI 1.10–9.70, I2= 73.8%, P for heterogeneity= 0.022) (Fig. 4). 
Three studies were included to explore the association between the 
presence of bronchial wall thickening in CT images and clinical severity 
of the disease. The pooled OR for the presence of bronchial wall thick-
ening in CT images of patients with severe disease, compared to the 
common type, was 11.64 (95% CI 1.81–74.66, I2= 81.8%, P for heter-
ogeneity= 0.004) (Fig. 5). Two studies were included to explore the 
association between the presence of crazy paving in CT images and 
clinical severity of the disease. Compared with the common type, the 
pooled OR for the presence of crazy paving in CT images of patients with 
severe disease was 7.60 (95% CI 3.82–15.14, I2= 84.3%, P for hetero-
geneity= 0.012) (Fig. 6). Substantial between-study heterogeneity was 
shown in results for three patterns of lesion namely, consolidation, 
linear opacity, and bronchial wall thickening. 
3.4. Lesion distribution 
Bilateral lung involvement has been explored in thirteen included 
studies. Compared with the common type, the polled OR for the pres-
ence of bilateral lung involvement in CT images of patients with severe 
disease was 3.44 (95% CI 1.74–6.79, I2= 63.9%, P for heterogeneity=
0.001) (Fig. 7). There was no evidence for substantial between study 
heterogeneity in results for bilateral lung involvement. 
3.5. Assessment of publication bias 
Begg’s and Egger’s regression tests provided no evidence of sub-
stantial publication bias except for GGO (P <0.1 for both tests). 
4. Discussion 
Our systematic review and meta-analysis of 18 studies involving 
3323 patients provides comprehensive information on the chest CT 
features associated with the severe cases of COVID-19 infection. Bron-
chial wall thickening was more likely to be associated with severe cases 
of COVID-19 infection, followed by crazy paving, linear opacity, and 
GGO. However, there was no significant association between the pres-
ence of consolidation and severity of clinical presentation. Considering 
the lesion distribution, as expected, bilateral lung involvement was more 
frequently associated with severe clinical presentation. 
Fig. 3. Forest plot showing the association between consolidation in chest CT images and severity of clinical presentation.  
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4.1. GGO 
GGO indicates an area of hazy increased lung opacity, less opaque 
than consolidation, through which vessels and bronchial structures may 
still be obscured. Although GGO is the most common CT feature of 
COVID-19 pneumonia, most studies did find no statistically significant 
difference in the presence of GGO between severe and common cases of 
COVID-19. Nevertheless, the meta-analysis of these studies indicated a 
37% increase in the risk of the presence of GGO in severe cases 
compared to the common type (Fig. 2). Since the GGO has been known 
as the typical early CT feature of COVID-19 pneumonia, it is advised that 
the small lesions, and especially new lesions, that contained an area of 
GGO requires follow-up to eliminate the possibility of COVID-19 pneu-
monia in high-risk subjects.21 
4.2. Consolidation 
Consolidation is often a middle-to-late stage feature in pulmonary 
infection. One study investigated the time course of lung changes at 
chest CT concluded the typical COVID-19 mainly starts with small GGOs 
in the lower lobes, which then develops into the crazy-paving pattern 
and subsequent consolidation.22 Although some studies indicated the 
association of consolidation with the severity of COVID-19 infection, 
others failed to show this association.5,15,23,24 The pooled analysis of 
these studies did not demonstrate any significant association between 
the presence of consolidation and the severity of clinical manifestations 
(Fig. 3). Consolidated tissue is more radio-opaque than normally aerated 
lung parenchyma, indicating the alveoli are completely filled by in-
flammatory exudation, hemorrhage, or pus. This feature could reflect 
the severity of lung involvement. The reason why this meta-analysis 
could not find a significant association between the presence of 
consolidation on the chest CT and severity of clinical presentation might 
be explained by the fact that in the included studies the chest CT scan 
had been performed at the early stage of the infection while consoli-
dation has been demonstrated to be noted on chest CT during disease 
progression.3 Thus, the time point from the onset of disease at which the 
chest CT is performed has a critical role in demonstrating the 
consolidation. 
4.3. Linear opacity 
The linear opacity, occurred in different interstitial lung disease, is 
typical for an evolution towards organizing pneumonia. Pooled analysis 
of studies evaluated the presence of linear opacity among patients with 
various disease severities indicated this finding is more likely to be 
observed in severe cases of COVID-19 than that observed in the common 
type (Fig. 4). Temporal analyzing of multiple chest CT scans demon-
strated a specific pattern during which linear opacity, observed 7–31 
days after disease onset, indicates sub-segmental atelectasis or second-
ary organizing pneumonia. This pattern might be representative of 
irreversible fibrosis.21,25 
4.4. Bronchial wall thickening 
Abnormal thickening of bronchial walls, arisen from various patho-
logical entities, usually indicates inflammation of the airways. A few 
studies investigated the association of bronchial wall thickening with 
the severity of COVID-19 infection, resulting in the conflicting findings. 
Fig. 4. Forest plot showing the association between linear opacity in chest CT images and severity of clinical presentation.  
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Fig. 5. Forest plot showing the association between bronchial wall thickening in chest CT images and severity of clinical presentation.  
Fig. 6. Forest plot showing the association between crazy paving in chest CT images and severity of clinical presentation.  
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Pooled analysis of these findings indicated significantly higher odds of 
bronchial wall thickening in severe cases of COVID-19 compared to the 
common type (Fig. 5). Airway wall thickening, which has been attrib-
uted to the high level of Vascular endothelial growth factor (VEGF), is 
suggested to reflect the duration and severity of disease and the degree 
of airflow obstruction in asthma.26,27 On the other hand, recent evi-
dence has revealed an increase in the levels of VEGF in COVID-19 pa-
tients,28 leading to the use of anti- VEGF medications in severe cases of 
COVID-19 infection in the context of clinical trial (https://clinicaltrials. 
gov/ct2/show/NCT04275414). The association of bronchial wall 
thickening with the severity of COVID-19 infection in this meta-analysis 
could be explained by the possible role of VEGF in the development and 
severity of bronchial wall thickening in COVID-19. 
4.5. Crazy paving 
Crazy paving defined as thickened interlobular septa and intra-
lobular lines superimposed on diffuse ground glass changes.29,30 
Several studies indicated as COVID-19 progresses this pattern can be 
noted on CT.22,31 Studies investigated the temporal changes of the CT 
features and its relation to disease onset showed crazy paving was 
frequently observed 10–14 days after the onset of the initial symp-
toms,32,33 however, the presence of crazy paving at early stages might 
be an indicator of rapid progression of the disease with poor prog-
nosis.32 Moreover, a recent review concluded that crazy paving can be a 
signal of COVID-19 entering a progressive stage.34 The results of this 
meta-analysis support the association of crazy paving feature on CT 
images with the severity of clinical outcomes suggesting this pattern 
could be considered as an alert in the management of patients. 
4.6. Bilateral lung involvement 
Many studies investigated the distribution of lung involvement in 
patients with various severities indicating the conflicting results. How-
ever, analysis of the pooled data showed bilateral lung involvement is 
3.44 times more likely to be observed in severe cases of COVID-19 
compared to the common type (Fig. 7). Irrespective of the disease 
severity, some previous studies indicated that bilateral lung involve-
ment is the most anatomic distribution of COVID-19 pneumonia.35,36 
4.7. Strength and limitation 
To the best of our knowledge, this meta-analysis is the first one that 
evaluated chest CT features associated with clinical severity of COVID- 
19 infection. Moreover, high quality studies with a relatively large 
number of participants have been included in this study. In addition, all 
studies included in this meta-analysis followed the same classification 
for determination of disease severity. 
However, this study has several limitations. First of all some features 
of chest CT imaging have not been included in the meta-analysis. 
Furthermore, some patients might have comorbidities such as chronic 
obstructive pulmonary disease (COPD) that could affect imaging 
appearance. Moreover, almost all included studies were retrospective 
that the results might be influenced by the confounding factors. In 
addition, because of different CT scanners and interpreting radiologists, 
the reported imaging features might be variable across sites. Lastly, this 
Fig. 7. Forest plot showing the association between bilateral lung involvement in chest CT images and severity of clinical presentation.  
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meta-analysis indicated a significant heterogeneity between the studies 
regarding some CT features. Moreover, results on GGO might be affected 
by the publication bias. 
5. Conclusion 
In summary, our meta-analysis of the observational studies shows 
bronchial wall thickening, crazy paving, linear opacity, and GGO are 
more likely to be associated with the severe type of COVID-19 compared 
to the common type. However, consolidation in chest CT was not asso-
ciated with the severity of clinical presentation. Regarding the lesion 
distribution, as expected, bilateral lung involvement was more likely to 
be observed in severe cases rather than common ones. Identification of 
the chest CT images associated with severe cases of COVID-19 is useful 
for early diagnosis and timely treatment of the severe and fatal cases of 
COVID-19 infection. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.clinimag.2020.12.037. 
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